Sclerema neonatorum
ICD-10 P83.0 is a billable code used to indicate a diagnosis of sclerema neonatorum.
Sclerema neonatorum is a rare but serious condition that primarily affects premature infants and those with low birth weight. It is characterized by a hardening of the skin, particularly in the subcutaneous tissue, leading to a thickened, indurated appearance. The condition typically presents within the first few days of life and can be associated with underlying systemic issues such as infections, metabolic disorders, or hypothermia. The skin changes are often most pronounced on the back, buttocks, and extremities, and may be accompanied by a decrease in skin turgor. The etiology of sclerema neonatorum is not fully understood, but it is believed to be related to an abnormal response to stressors in the neonatal period. Management focuses on supportive care, maintaining normothermia, and addressing any underlying conditions. Early recognition and intervention are crucial to improve outcomes for affected infants.
Detailed clinical notes describing the onset, progression, and treatment of sclerema neonatorum are essential. Include observations of skin texture, associated symptoms, and any interventions performed.
Common scenarios include premature infants presenting with skin hardening in the NICU, often in conjunction with other complications such as respiratory distress or infection.
Neonatologists should ensure that all relevant clinical data is documented to support the diagnosis and treatment plan, as well as to justify the use of P83.0 in coding.
Pediatricians must document any history of prematurity, low birth weight, or other risk factors that may contribute to the development of sclerema neonatorum.
Pediatric scenarios may involve follow-up visits for infants previously diagnosed with sclerema neonatorum, monitoring for skin changes and overall health.
Consideration should be given to the long-term implications of sclerema neonatorum on skin health and development in pediatric patients.
Used when managing an infant with sclerema neonatorum requiring intensive monitoring and intervention.
Documentation must include the severity of the condition, interventions performed, and the infant's response to treatment.
Neonatologists should ensure that all critical care elements are documented to support billing.
Key clinical features include hardening of the skin, particularly in the back and extremities, decreased skin turgor, and potential association with systemic issues such as infections or metabolic disorders.
